Tuesday rolls around and I make my way to rheumy's office (not an easy task on public transportation in NYC; think few escalators and even fewer elevators). Since we all love good news, I'll give to you first - there was nothing unusual about my blood work; bad news - I can't participate in the drug study. Because it is an IL-6 and works within the body similar to Actemra, rheumy doesn't feel comfortable taking a chance. While disappointed, I had to agree with him. I never want to go back to that feeling of having an elephant sitting on my chest.We discussed the options: 1. start Rituxan, sorry I don't think so, can't wrap my mind around that at least not yet; 2. wait for next drug study, okay if it starts within next 1-1 1/2 months; 3. add Arava (as a stop-gap measure) and remove Tramadol (honestly, it wasn't really doing much for pain) from drug regimen. So I opted for 2 & 3.
I can't imagine how people used to think that docs had all the answers to me medicine is just an experiment on a really grand scale. You know, let's try this combo and if that doesn't work we can try this combo over here. I am not disparaging docs, after all where would I be without my trusted rheumy?; but you have to agree that it is all experimental and we are the animal looking for the reward (read as: magic bullet to remission).
We are our best advocates. Present me with the options and let me make an informed decision, after all it's my body with all it's aches and pains.
www.actemra.com

No comments:
Post a Comment